Falco Holdings Co Ltd operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Falco Holdings Co Ltd with three other
pharmaceutical manufacturers in Asia:
Thyrocare Technologies Ltd
sales of 3.56 billion Indian Rupees [US$50.28 million]
Dr. Lal PathLabs Ltd
(10.57 billion Indian Rupees [US$149.13 million]
of which 100%
was Healthcare), and
Medical & Biological Laboratories Company Limited
(7.07 billion Japanese Yen [US$63.72 million]
of which 99%
was Reagent business).
Falco Holdings Co Ltd reported sales of ¥45.96 billion (US$414.12 million)
March of 2018.
decrease of 0.0%
versus 2017, when the company's sales were ¥45.97 billion.
Contributing to the drop in overall sales was the 0.3% decline
in Medical Test, from ¥27.85 billion to ¥27.77 billion.
However, these declines were partially offset by the increase in sales of
Preparation of Drugs (up 0.4% to ¥18.19 billion)